Search Sustopedia

MetricAntimicrobial use in animal production

Animal production or sourced animal protein share receiving medically important antimicrobials

Measurement answer

What this metric measures

Reports, by animal type, the proportion of animal production or animal protein sourced that receives medically important antimicrobials and the proportion that does not.

Specification

Metric specification

Result format
Structured table
Unit
% — source-defined reporting unit
Reporting basis
Organization's reporting period; duration is not specified in the extracted source text.
Aggregation
Percentage of the declared animal-production or sourced-animal-protein denominator, reported separately for each animal type and for both receipt statuses.
Pillar
Social
Topic
Antimicrobial use in animal production
Controlled domain
Pollution
Entity type
Metric

Reporting boundary

Animal production or animal protein sourced by the organization, using the declared denominator basis and categorized by animal type.

Verified source occurrences

Framework coverage

This is one canonical metric. The bindings below show every verified framework occurrence without creating duplicate metric pages. Edition, disclosure, role, and relationship remain source-specific.

  • Adopting Disclosure

    TNFD sector guidance

    Source evidence
    Publisher
    Taskforce on Nature-related Financial Disclosures
    Edition
    Final English sector guidance collection through August 2026 (17 documents)
    Requirement
    Not Specified
    Relationship
    Defines Disclosure
    Mapping outcome
    Direct Evidence
    Source locator
    TNFD additional sector guidance, Section 3.3, Table 12, p. 75: “Report the proportion of animal production or animal protein sourced that receives medically important antimicrobials and the proportion that does not, categorized by animal type.” | Page 75, Section 3.3, Table 12
    Open official framework source
  • Adopting Disclosure

    TNFD sector guidance

    FA.A4.0
    Publisher
    Taskforce on Nature-related Financial Disclosures
    Edition
    Version 1.0, June 2024
    Requirement
    Recommended
    Relationship
    Maps Source Identity
    Mapping outcome
    Published
    Source locator
    Page 75, Section 3.3, Table 12
    Open official framework source

Value structure

Dimensions and units

Unit
% — source-defined reporting unit
Reporting basis
Organization's reporting period; duration is not specified in the extracted source text.

Unit meaning: Values use % under the disclosed TNFD sector-guidance method, reporting period and boundary.

Table fields and units

  • animal type
  • denominator basis
  • share receiving medically important antimicrobials (%)
  • share not receiving medically important antimicrobials (%)

Published dimensions

  • animal type
  • denominator basis: animal production or animal protein sourced
  • receipt status: receives medically important antimicrobials; does not receive medically important antimicrobials

Calculation method

Formula information

Status
Specified
Formula type
Percentage

Formula

For each animal type and declared denominator basis: P_received = (N_received / D) × 100; P_not_received = (N_not_received / D) × 100.

Apply the source-defined TNFD sector-guidance method within the stated reporting boundary. This is a standalone two-field percentage disclosure with an explicit outcome and animal-type categorization. It is not the same construct as the shortlisted general antibiotic-receipt metric because this source specifically limits the numerator to medically important antimicrobials and requires the reciprocal non-receipt field.

Variables

SymbolVariableDefinitionUnit
P_receivedShare receiving medically important antimicrobialsPercentage of the declared denominator that receives medically important antimicrobials.%
P_not_receivedShare not receiving medically important antimicrobialsPercentage of the declared denominator that does not receive medically important antimicrobials.%
N_receivedAnimal production or sourced animal protein receiving medically important antimicrobialsNumerator for the receipt-status share for the relevant animal type.same unit as D
N_not_receivedAnimal production or sourced animal protein not receiving medically important antimicrobialsNumerator for the non-receipt-status share for the relevant animal type.same unit as D
DDeclared animal-production or sourced-animal-protein denominatorTotal animal production or animal protein sourced for the relevant animal type and selected basis.declared production or protein unit

Verified sources

Evidence and status sources

Sustopedia checked each record-specific claim directly against primary publisher material. Labels distinguish current measurement authority from future compatibility and corroborative, legal, edition, or method status context. Corroborative evidence can support a stated limitation but cannot establish the core measurement by itself.

Measurement evidence

  • Measurement evidenceChecked 30 August 2026

    TNFD additional sector guidance collection

    Publisher
    Taskforce on Nature-related Financial Disclosures
    Edition
    Final English sector guidance collection through August 2026 (17 documents)
    Locator
    TNFD additional sector guidance, Section 3.3, Table 12, p. 75: “Report the proportion of animal production or animal protein sourced that receives medically important antimicrobials and the proportion that does not, categorized by animal type.” | Page 75, Section 3.3, Table 12

    Supports: The official TNFD sector guidance supports the identity, boundary and method basis of “Animal production or sourced animal protein share receiving medically important antimicrobials”.

    Open official source

Use with context

Interpretation boundaries

Method disclosures required

Source-edition basis: TNFD sector guidance, Final English sector guidance collection through August 2026 (17 documents).

  • Definition or authoritative classification used for medically important antimicrobials.
  • Selected denominator basis: animal production or animal protein sourced.
  • Animal types included and classification method.
  • Production, sourcing, ownership, supplier-tier, and geographic coverage.
  • Method for determining whether antimicrobials were received during the reporting period.

Record-specific limitations

  • The extracted specification does not define medically important antimicrobials or prescribe a classification list.
  • The source permits an animal-production or sourced-animal-protein basis; results are not directly comparable unless the selected denominator basis is disclosed.
  • The extracted text does not specify a geographic, ownership, or supplier-tier boundary.

Interpret this metric with the stated reporting boundary, period convention, value shape, and unit. Results prepared with different boundaries or conventions may not be directly comparable.

Measurement evidence supports the core record-specific claims described above. Corroborative evidence can support limitations, while compatibility and status sources provide their separately labelled context. None of these cards by itself determines an organisation's legal applicability, filing readiness, assurance status, or compliance conclusion.